• 35375 Citations
  • 101 h-Index
1978 …2023
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1978 2019

Filter
Article
2019
Sclerosing Cholangitis
Cholangiocarcinoma
Practice Guidelines
Gallbladder Neoplasms
Neoplasms
1 Citation (Scopus)

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Early Detection of Cancer
Cholangiocarcinoma
Neoplasms
Inflammatory Bowel Diseases

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Registries
Demography
Patient Reported Outcome Measures
Databases
1 Citation (Scopus)

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. & LaRusso, N. F., Jan 1 2019, In : Scandinavian Journal of Gastroenterology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Curcumin
Alkaline Phosphatase
Safety
Serum

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
Cholangitis
Fibrosis
Therapeutics
Survival
Patient Advocacy
1 Citation (Scopus)

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

Esophageal and Gastric Varices
Varicose Veins
ROC Curve
Fibrosis
Digestive System Endoscopy
1 Citation (Scopus)

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
4 Citations (Scopus)

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Jan 1 2019, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Liver
2018
1 Citation (Scopus)

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

Cholangitis
Antibodies
Autoimmune Hepatitis
Muscles
2 Citations (Scopus)

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
Fibric Acids
Cholangitis
Pruritus
Bezafibrate
Ursodeoxycholic Acid
6 Citations (Scopus)

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Cholangitis
Health
Ursodeoxycholic Acid
African Americans
Liver Diseases
5 Citations (Scopus)

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

Cholangitis
Hispanic Americans
Liver Transplantation
Mortality
Transplants
7 Citations (Scopus)

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

Cholangitis
Mortality
Ursodeoxycholic Acid
Incidence
Therapeutics
20 Citations (Scopus)

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Liver
Incidence
Fibrosis

Managing PBC: Expanding the Provider Comfort Zone

Chascsa, D. M. & Lindor, K., Jun 9 2018, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 1 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

Cholangitis
Natural History
Ursodeoxycholic Acid
Paris
Gastroenterology
32 Citations (Scopus)

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, K., Bowlus, C. L., Boyer, J., Levy, C. & Mayo, M., Jan 1 2018, (Accepted/In press) In : Hepatology.

Research output: Contribution to journalArticle

Cholangitis
4 Citations (Scopus)

Primary sclerosing cholangitis, part 1: Epidemiology, etiopathogenesis, clinical features, and treatment

Tabibian, J. H., Ali, A. H. & Lindor, K., May 1 2018, In : Gastroenterology and Hepatology. 14, 5, p. 293-304 12 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Epidemiology
Liver Transplantation
Therapeutics
End Stage Liver Disease
4 Citations (Scopus)

Primary sclerosing cholangitis, part 2: Cancer risk, prevention, and surveillance

Tabibian, J. H., Ali, A. H. & Lindor, K., Jul 1 2018, In : Gastroenterology and Hepatology. 14, 7, p. 427-432 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Neoplasms
Cholangiocarcinoma
Expert Testimony
Gallbladder
19 Citations (Scopus)

Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis

Ali, A. H., Tabibian, J. H., Nasser-Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., Hilscher, M., Silveira, M. G., Carey, E. J. & Lindor, K., Jun 1 2018, In : Hepatology. 67, 6, p. 2338-2351 14 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Neoplasms
Gallbladder
Survival
2017
16 Citations (Scopus)

An update on cancer risk and surveillance in primary sclerosing cholangitis

Horsley-Silva, J. L., Rodriguez, E. A., Franco, D. L. & Lindor, K., 2017, (Accepted/In press) In : Liver International.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Gallbladder Neoplasms
Colorectal Neoplasms
Neoplasms
15 Citations (Scopus)

A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H. & Lindor, K., Mar 1 2017, In : American Journal of Therapeutics. 24, 2, p. e167-e176

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Fatigue
Randomized Controlled Trials
Placebos
Safety
11 Citations (Scopus)

Curcumin in hepatobiliary disease: Pharmacotherapeutic properties and emerging potential clinical applications

Hu, R. W., Carey, E. J., Lindor, K. & Tabibian, J. H., Nov 1 2017, In : Annals of Hepatology. 16, 6, p. 835-841 7 p.

Research output: Contribution to journalArticle

Curcumin
Curcuma
Sclerosing Cholangitis
Rhizome
Cholangiocarcinoma
2 Citations (Scopus)

Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters

Martin, P. & Lindor, K., Sep 30 2017, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Liver Transplantation
16 Citations (Scopus)

Old and new treatments for primary biliary cholangitis

Chascsa, D., Carey, E. J. & Lindor, K., Apr 1 2017, In : Liver International. 37, 4, p. 490-499 10 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Alkaline Phosphatase
Histology
Chenodeoxycholic Acid
100 Citations (Scopus)

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

on behalf of the & International PSC Study Group, Jun 1 2017, In : Gastroenterology. 152, 8, p. 1975-1984.e8

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Phenotype
Liver Transplantation
Neoplasms
2016
21 Citations (Scopus)

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Alkaline Phosphatase
Biomarkers
Survival
Liver Transplantation
289 Citations (Scopus)

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

Cholangitis
Placebos
Ursodeoxycholic Acid
Bilirubin
Alkaline Phosphatase
10 Citations (Scopus)

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Fluorescence In Situ Hybridization
Cholangiocarcinoma
Liver Transplantation
Cholangiography
10 Citations (Scopus)

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jul 14 2016, (Accepted/In press) In : Journal of Clinical Gastroenterology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Tretinoin
Bile Acids and Salts
Alanine Transaminase
10 Citations (Scopus)

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

Cholangitis
Pharmaceutical Preparations
Ursodeoxycholic Acid
Therapeutics
HLA Antigens
8 Citations (Scopus)

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Antibodies
Control Groups
Bilirubin
Alkaline Phosphatase
6 Citations (Scopus)

Oral vancomycin therapy in a child with primary sclerosing cholangitis and severe ulcerative colitis

Buness, C., Lindor, K. & Miloh, T., 2016, In : Pediatric Gastroenterology, Hepatology and Nutrition. 19, 3, p. 210-213 4 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Vancomycin
Ulcerative Colitis
Bile Ducts
Anti-Bacterial Agents
17 Citations (Scopus)

Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)

Chawla, K. S., Talwalkar, J. A., Keach, J. C., Malinchoc, M., Lindor, K. & Jorgensen, R., Dec 31 2016, In : BMJ Open Gastroenterology. 3, 1, e000069.

Research output: Contribution to journalArticle

Fatty Liver
Reproducibility of Results
Liver Diseases
Chronic Disease
Quality of Life
64 Citations (Scopus)

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study

Trivedi, P. J., Lammers, W. J., Van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., Poupon, R., Mayo, M. J., Burroughs, A. K., Nevens, F., Mason, A. L., Kowdley, K. V., Lleo, A., Caballeria, L., Lindor, K., Hansen, B. E. & 1 others, Hirschfield, G. M., Feb 1 2016, In : Gut. 65, 2, p. 321-329 9 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Multicenter Studies
Hepatocellular Carcinoma
Kaplan-Meier Estimate
North America
6 Citations (Scopus)

The management of autoimmunity in patients with cholestatic liver diseases

Ali, A. H., Carey, E. J. & Lindor, K., Jan 2 2016, (Accepted/In press) In : Expert Review of Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Autoimmunity
Liver Diseases
Autoimmune Diseases
Sclerosing Cholangitis
Cholangitis
5 Citations (Scopus)

The Microbiome and Primary Sclerosing Cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Sep 1 2016, In : Seminars in Liver Disease. 36, 4, p. 340-348 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Microbiota
End Stage Liver Disease
Probiotics
Ulcerative Colitis
43 Citations (Scopus)

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group, Jul 1 2016, In : Hepatology. 64, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Alkaline Phosphatase
Bile Acids and Salts
Liver Cirrhosis
2015
158 Citations (Scopus)

ACG clinical guideline: Primary sclerosing cholangitis

Lindor, K., Kowdley, K. V. & Harrison, M. E., May 8 2015, In : American Journal of Gastroenterology. 110, 5, p. 646-659 14 p.

Research output: Contribution to journalArticle

Bile Duct Neoplasms
Avitaminosis
Ursodeoxycholic Acid
Sclerosing Cholangitis
Metabolic Bone Diseases
67 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Hepatology. 62, 5, p. 1620-1622 3 p.

Research output: Contribution to journalArticle

43 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Journal of Hepatology. 63, 5, p. 1285-1287 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Disease Progression
16 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Oct 1 2015, In : Clinics and Research in Hepatology and Gastroenterology. 39, 5, p. e57-e59 800.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Terminology
Fibrosis
20 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Gut. 64, 11, p. 1671-1672 2 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Digestive and Liver Disease. 47, 11, p. 924-926 3 p., 2950.

Research output: Contribution to journalArticle

21st Century History
19th Century History
20th Century History
Cholangitis
Biliary Liver Cirrhosis
21 Citations (Scopus)

Changing nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : American Journal of Gastroenterology. 110, 11, p. 1536-1538 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Patient Preference
Terminology
Fibrosis
47 Citations (Scopus)

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Gastroenterology. 149, 6, p. 1627-1629 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Fibrosis
11 Citations (Scopus)

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Clinical Gastroenterology and Hepatology. 13, 11, p. 1867-1869 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Fibrosis
133 Citations (Scopus)

Development and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

Lammers, W. J., Hirschfield, G. M., Corpechot, C., Nevens, F., Lindor, K., Janssen, H. L. A., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Parés, A., Burroughs, A. K., Mason, A. L., Kowdley, K. V., Kumagi, T., Harms, M. H., Trivedi, P. J., Poupon, R., Cheung, A. & 4 others, Lleo, A., Caballeria, L., Hansen, B. E. & Van Buuren, H. R., Dec 1 2015, In : Gastroenterology. 149, 7, p. 1804-1812e4

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Paris
Survival
Therapeutics
7 Citations (Scopus)

Docetaxel Induced Sclerosing Cholangitis

Horsley-Silva, J. L., Dow, E. N., Menias, C. O., Smith, M. L., Carballido, E. M., Lindor, K. & Vargas, H. E., Dec 1 2015, In : Digestive Diseases and Sciences. 60, 12, p. 3814-3816 3 p.

Research output: Contribution to journalArticle

docetaxel
Tosyl Compounds
Propanolamines
Adrenergic alpha-1 Receptor Antagonists
Carbazoles
2 Citations (Scopus)

Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease

Tabibian, J. H. & Lindor, K., Mar 1 2015, In : Alimentary Pharmacology and Therapeutics. 41, 5, p. 490 1 p.

Research output: Contribution to journalArticle

Betaretrovirus
Autoimmune Hepatitis
Biliary Liver Cirrhosis
Liver Diseases
Hepatocytes